Early research (Phase 1)Study completedNCT02199379
What this trial is testing
A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects
Who this might be right for
Renal ImpairmentDisease Severity
Eisai Inc. 26